Clinical Trial Update: Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy

View source ↗

Summary

This completed trial update reports how RSV monoclonal antibody therapy was used and how compliant sites were with its administration for RSV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Respiratory Tract Infection
• Respiratory Syncytial Virus Infection

Drugs mentioned

• Palivizumab (Palivizumab)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Lower Respiratory Tract Infection, Respiratory Syncytial Virus Infections | Status: COMPLETED